Genome Korea in Ulsan Launched

ULSAN, KOREA - Nov 25, 2015 -  The Ulsan 10,000 Genome Project, entitled the "Genome Korea in Ulsan" has been launched in Ulsan Metropolitan City on the 25th of Nov

Genedata Announces AstraZeneca Standardizes on Genedata Screener as its Global Screening Platform

BASEL, N/A, SWITZERLAND - Nov 20, 2015 - Genedata, a leading provider of advanced software solutions for drug discovery and life science research, today announced it has signed a five-year license agreement with AstraZeneca

JUNIPER PHARMA SERVICES STRENGTHENS CAPSULE CAPABILITY WITH XCELODOSE

NOTTINGHAM, UNITED KINGDOM - Nov 19, 2015 - Nottingham, UK – Juniper Pharma Services, a subsidiary of Juniper Pharmaceuticals, Inc. (Nasdaq: JNP), has reinforced its early stage capsule filling expertise with the expansion of its Xcelodose® powder micro-dosing system as part of its suite of GMP capabiliThe move by the contract development and manufacturing organisation (CDMO) follows demand from its clients to develop the technique to complement its development services and help get new molecules to Phase I clinical trials quicker

COGSTATE IPAD COGNITIVE ASSESSMENTS SELECTED FOR USE IN PHASE IV OBSERVATIONAL STUDY OF APPROVED TREATMENTS FOR PROSTATE CANCER

- Nov 18, 2015 - Cogstate Ltd (ASX: CGS), leaders in the measurement of cognition in clinical trials, is pleased to announce that their iPad-based computerized cognitive assessment technology has been selected for use in a multicenter Phase IV observational study to assess the tolerability of two approved drugs for the treatment of Metastatic Castration-Resistant Prostate Cancer (mCRPC)

BC Platforms Appoints Mark Daly as Chairman of its Scientific Advisory Board and Expands Senior Management Team in the US

HELSINKI, FINLAND - Nov 16, 2015 - BC Platforms today announced that it has appointed Mark Daly as the Chairman of its Scientific Advisory Board (SAB) and expanded its senior management team who will be located at its new US headquarters in Cambridge, Massachusetts, USA

Dr. Adam Marsh of Genome Profiling, LLC to Present at the Cancer Diagnostics Conference in San Franc(1)

NEWARK, DE - Nov 12, 2015 - Genome Profiling, LLP (GenPro), an epigenetic biomarker discovery company to clinical research institutions, biopharma and diagnostics companies, announced that Adam Marsh, Ph

Dr. Adam Marsh of Genome Profiling, LLC to Present at the Cancer Diagnostics Conference in San Francisco on November 16, 2015

NEWARK, DE - Nov 12, 2015 - Genome Profiling, LLP (GenPro), an epigenetic biomarker discovery company to clinical research institutions, biopharma and diagnostics companies, announced that Adam Marsh, Ph

Scientists Publish Unique Genomic Discoveries with Single Molecule, Real-Time Sequencing

ST. LOUIS, MO, UNITED STATES - Nov 11, 2015 - A new paper released in Nature today reported the virtually complete draft genome of Oropetium thomaeum, a grass species that can regrow after exposed to extreme drought when water becomes available

NewLeaf Symbiotics Receives Key US Production Patent

ST. LOUIS, UNITED STATES - Nov 11, 2015 - The US Patent and Trademark Office has granted NewLeaf Symbiotics US Patent No. 9,181,541 for its Microbial Fermentation technology

University of Chicago Graham School Launches Master of Science Degree in Biomedical Informatics

CHICAGO, IL - Nov 5, 2015 - Biomedical informatics, one of the world’s fastest-growing interdisciplinary fields, is the latest graduate degree program offered by the University of Chicago Graham School of Continuing Liberal and Professional Studies

Aridhia Announces Northern Ireland Based Alzheimer's Research Collaboration to Benefit from AnalytiXagility Workspace

EDINBURGH, UK - Nov 5, 2015 - Aridhia, the Edinburgh based clinical informatics company, announced today that their AnalytiXagility data platform has been chosen to underpin a three year research programme that was awarded Innovate UK funding via the Neurodegenerative Diseases: Business Models and Big Data competition, following a joint bid by three of Northern Ireland’s leading organisations

Congenica and GenomOncology announce collaborative agreement at AMP

CAMBRIDGE, UK - Nov 5, 2015 - Congenica, leader in genomic interpretation and diagnostics in rare genetic disease, and GenomOncology, specialists in precision medicine technology in the field of oncology, are announcing a pilot collaboration that will support the commercialisation of each other’s products in the USA and UK respectively and offer strategic partners a scalable data platform

MAVERIX ANNOUNCES “MAGIX” GRANT PROGRAM TO ACCELERATE GENE EXPRESSION RESEARCH USING RNA-SEQ

SAN MATEO - Nov 3, 2015 - Maverix Biomics, Inc., a leading genomic analysis software company, today announced a grant program designed to foster the rapid adoption and acceleration of gene expression research using Next Generation Sequencing (NGS)

Cancer, Meet the Alamo: San Antonio Enlists WuXi NextCODE to Speed Unparalleled Open-access Cancer Genome Project

CAMBRIDGE, MA - Nov 3, 2015 -  

• The San Antonio 1000 Cancer Genome Project is collecting tumor and normal patient samples in the ten most common cancers from across a single metropolitan area
• WuXi NextCODE's CLIA laboratory will have sequenced the majority by year endx

CCDC Blind Test Showcases Major Advance in Crystal Structure Prediction Methods

CAMBRIDGE, UK - Nov 3, 2015 - The Cambridge Crystallographic Data Centre (CCDC) announces that the results of its 6th blind test of crystal structure prediction methods demonstrate significant advancement in crystal structure prediction methods in comparison with previous testsx

Tute Genomics Acquires Knome

PROVO, UT - Nov 2, 2015 -   Tute Genomics, the leader in clinical sequencing informatics, today announced the acquisition of key assets of Knome, a renowned human-genome interpretation company whose systems and services helped spearhead several of the greatest commercial advancements in modern human genetics

FDA Equips its Pharmacometrics Teams with Certara’s Phoenix Software

PRINCETON, NJ, USA - Nov 2, 2015 - Certara®, the global biosimulation technology-enabled drug development company, today announced that the United States Food and Drug Administration (FDA) has outfitted its pharmacometrics teams with Certara’s Phoenix® software

Creative Bioarray Introduces Cryopreserved Mesenteric Cells for Biologists

NEW YORK, NY - Oct 30, 2015 - Creative Bioarray, an innovative biotechnology company who produces the world's most comprehensive list of research-use cells, including tumor cells, primary cells, stem cells and transformed cells, etc, recently announced its new cryopreserved mesenteric cells for researchers, aiming to provide customers more tools for scientific study

BC Platforms to Collaborate with Helsinki University Hospital to Apply its Proprietary Genomics Management Platform to Provide Clinical Benefits for Cancer Patients

HELSINKI, FINLAND - Oct 26, 2015 - BC Platforms, a world leader in genomic data management solutions, today announced that it has signed a partnership agreement with Helsinki University Hospital to use its genomic management platform to integrate, analyze and interpret their extensive clinical and genealogy data with next-generation sequencing data to provide innovative, personalized treatment options for breast cancer patients at the hospital

CSM Held Successful Grand Opening of New Clinical Trial Supply Facility in Malvern with Elected Officials

MALVERN, PA - Oct 21, 2015 - CSM welcomed over 100 attendees to celebrate the opening of its second facility in the Great Valley Corporate Center of Malvern, Pennsylvania